Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.
Johanna Elin GehinGuro Løvik GollDavid John WarrenSilje Watterdal SyversenJoseph SextonEldri Kveine StrandTore Kristian KvienNils BolstadElisabeth LiePublished in: Arthritis research & therapy (2019)
NCT01581294, April 2012.